The U.S. Food and Drug Administration (FDA) said Monday that two other drugs might be linked to the fungal meningitis outbreak that has infected 200 people and killed 15 in recent weeks.
The two other drugs were made by the same Massachusetts pharmacy, the New England Compounding Center, the FDA said.
The agency said it is investigating a case of possible meningitis, a noncontagious infection, with an epidural injection of triamcinolone acetonide.
Two other transplant patients with Aspergillus fumigatus who received a cardioplegic solution from the pharmacy during surgery were also reported, the FDA said. Aspergillus is one fungus linked to the meningitis outbreak; the other fungus is Exserohilum, which is not as easy to detect, according to the agency.
The U.S. Centers for Disease Control and Prevention on Monday said that the number of meningitis cases has grown to 214 cases across 15 states.
Symptoms and signs of a possible meningitis infection include a new or persistent headache, fever, a stiff neck, nausea, vomiting, as well as chest pain, visual changes, or pain, redness, and discharge from the eye, said the FDA.
The Epoch Times publishes in 35 countries and in 19 languages. Subscribe to our e-newsletter.